Malignant Hypertensive Retinopathy-Clinical and Fundus Manifestations in Patients with New Onset or Acute Exacerbation of Chronic Hypertension

Chang Gung Medical Journal

Volumn 26, Issue 9, 2003, Pages 669-677

  Chen, Yi Hao ^b   Kuo, Hsi Kung ^a   Kao, Min Lun ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Malignant hypertension; Malignant hypertensive retinopathy

Indexed keywords

ACUTE DISEASE; ADOLESCENT; ADULT; AUTOIMMUNE DISEASE; BLOOD DYSCRASIA; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; EARLY DIAGNOSIS; EYE PHOTOGRAPHY; FEMALE; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; INFECTION; KIDNEY FAILURE; MALE; ONSET AGE; OPHTHALMOLOGY; OPHTHALMOSCOPY; REVIEW; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; STROKE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE;

ADULT; CHILD; CHRONIC DISEASE; FEMALE; FUNDUS OCULI; HUMANS; HYPERTENSION, MALIGNANT; MALE; MIDDLE AGED; OPHTHALMOSCOPY; RETINAL DISEASES; VISUAL ACUITY;

EID: 0242596480     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Schachat PA. Medical Retina. Ed. III. Mosby, Inc. 2001;1404-9.
2. Keith NM, Wagener HP, Kernohan JW. The syndrome of malignant hypertension. Arch Intern Med 1928;41:141-88.
3. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939;197:332-9.
4. Richard JG. Current therapy in nephrology and hypertension. The CV Mosby Company. 1984-1985;324-33.
5. World Health Organization. Areerial hypertension. World Health Organ Tech Rep Ser 1978;628:7-56.
6. McGregor E, Isles CG, Jay JL, Lever AF, Murray GD. Retinal changes in malignant hypertension. Br. Med J 1986;63292:233-4.
7. Catto MD. Management of renal hypertension. Lancaster: MTP, 1988:41-74.
8. Lawrence RK. Management of the hypertensive patient. Churchill Livingstone Inc. 1995;195-204.
9. Ahmed ME, Walker JM, Beevers DG, Beevers M. Lack of difference between malignant and accelerated hypertension. Br Med J 1986;292:235-7.
10. Hermann D. Schubert HD. Ocular manifestations of systemic hypertension. Curr Opin Ophthalmol 1998;9:69-72.
11. Klein R. Retinopathy in a population-based study. Trans Am Ophth Soc 1992;90:561-94.
12. Klein R, Klein B, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing and arteriovenous nicking in a population. Arch Ophthalmol 1994;112:92-8.
13. Yu T, Mitchell P, Berry G, Li W, Wang J. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 1998;116:83-9.
14. Mathews KD. Hypertensive encephalopathy in childhood. J Child Neurol 1996;11:193-6.
15. Heidbreder E, Huller U, Schafer B, Heidland A. Severe hypertensive retinopathy. Increased incidence in renoparenchymal hypertension. Am J Nephrol 1987;7:394-400.
16. Hayreh S, Servais G, Virdi P, Macus M, Rojas P, Woolson R. Fundus lesions in malignant hypertension: III. Arterial blood pressure, biochemical, and fundus changes. Ophthalmology 1986;93:45-59.
17. Hayreh S, Servais S, Virdi P. Fundus lesions in malignant hypertension: IV Focal intraretinal periarterial transudates. Ophthalmology 1986;93:60-73.
18. Kahn MT, Liao HR. Focal intraretinal periarteriolar transudates in malignant hypertensive retinopathy- A case report. Transactions of the ophthalmological society of the Republic of China 1987;26:474-7.
19. Wu WC, Chen ZJ, Wang HZ. The early characteristic finding in malignant hypertensive retinopathy. J Clin Ophthalmology 1988;6:5-6 (in Chinese).
20. Olk RJ. Diabetic retinopathy. J.B. Lippincott Company. 1993;176-7.
21. Browning AC, Mengher LS, Gregson RM, Amoaku WM. Visual outcome of malignant hypertension in young people. Arch Dis Child 2001;85:401-3.